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We	 describe	 a	 PCR-confirmed	 case	 of	 Plasmodium 
knowlesi infection with a high parasitemia level and clini-
cal signs of severe malaria in a migrant worker from Malay-
sian	Borneo	in	the	Netherlands.	Investigations	showed	that	
commercially available rapid antigen tests for detection of 
human Plasmodium infections can detect P. knowlesi infec-
tions in humans.
T
he malaria parasite Plasmodium knowlesi naturally oc-
curs in long-tailed and pig-tailed macaques that inhabit 
forested areas in Southeast Asia. P. knowlesi can be trans-
mitted from monkeys to humans by the bite of an infected 
mosquito (1), but infection with P. knowlesi was tradition-
ally regarded as a rare disease, occurring only sporadically 
in humans. However, recent findings of a large number 
of infected patients in Malaysian Borneo; other reports of 
human cases in Thailand, Myanmar, the Philippines, and 
Singapore; and some reports of P. knowlesi malaria ac-
quired by travelers to the Malaysian Borneo suggest that 
P. knowlesi may be more widespread among humans than 
previously thought (2–7).
Unfortunately, microscopic analysis of asexual stages 
of P. knowlesi can misidentify these parasites as P. ma-
lariae (3,4). Unlike P. malariae, which multiplies every 3 
days in the blood and never results in severe infections, P. 
knowlesi multiplies daily, and high parasitemia with death 
in humans can occur (4). Therefore, early diagnosis and 
immediate treatment is warranted. Although PCR and se-
quencing are used in species confirmation, a more rapid 
diagnostic test would be a useful tool for delivering prompt 
and adequate medical treatment. We report a case of im-
ported P. knowlesi infection in the Netherlands in a migrant 
worker from Malaysian Borneo. This P. knowlesi infection 
was detected by commercially available rapid diagnostic 
antigen tests for malaria.
The Case
A 38-year-old man came to the Netherlands in January 
2009 to work as a rigger in the harbor of Rotterdam. Since 
October 2008, he had lived in Kapit, Sarawak, in Borneo 
and hunted wild animals in the surrounding jungles. One 
week after arriving in the Netherlands, he came to our hos-
pital with a 5-day history of fever, myalgia, headache, and 
low back pain. His medical history was uneventful, and he 
had not experienced any previous malaria attacks.
Physical examination showed a temperature of 40.0°C 
and remarkable jaundice. Abdominal examination showed 
no abnormalities. Laboratory investigations showed a mod-
erate  anemia  (hemoglobin  7.8  mmol/L  [reference  range 
8.5–11.0 mmol/L]), a normal leukocyte count (5.8 × 109/L 
[reference range 4.3–10 × 109/L]), thrombocytopenia (plate-
let count 22 × 109/L [reference range 150–400 × 109/L]), 
an increased level of C-reactive protein (158 mg/L [refer-
ence range <10 mg/L]), and liver function abnormalities 
(serum alanine aminotransferase 199 U/L [reference range 
<41 U/L]; aspartate aminotransferase 128 U/L [reference 
range <37 U/L]; lactate dehydrogenase [LDH] 1,059 U/L 
[reference range  <450  U/L]; gamma-glutamyltransferase 
183 U/L [reference range <50 U/L]; alkaline phosphatase 
285 U/L [reference range <120 U/L]; and total bilirubin 
99 µmol/L [reference range <17 µmol/L]). Plasma lactate 
level was within normal limits.
In a rapid diagnostic test for malaria (BinaxNOW Ma-
laria Test; Binax, Inc., Scarborough, ME, USA), his blood 
sample was negative for P. falciparum histidine-rich protein 
2 but showed a positive reaction with pan-malarial aldolase 
antigen, which suggested a non–P. falciparum infection. 
Results of quantitative buffy coat analysis were positive 
for  malaria  trophozoites,  schizonts,  and  gametocytes.  A 
thin  blood  film  showed  parasite  density  of  2%  infected 
erythrocytes  (84,000  trophozoites/µL),  schizonts,  and 
gametocytes with an inconclusive morphologic appearance     
(Figure 1). A P. knowlesi infection was suspected because 
of his recent stay in Kapit, Malaysian Borneo. The patient 
was treated orally with chloroquine, 10 mg/kg, followed by 
5 mg/kg after 6, 24, and 48 hours, which resulted in a rapid 
relief of symptoms and fever. Results of quantitative buffy 
coat analysis, pan-malarial aldolase antigen reactivity, and 
thick and thin blood smears were negative within 40 hours 
after administration of chloroquine.
Subsequently, PCR analysis of blood samples taken 
at admission was performed to determine the Plasmodium 
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species. Human Plasmodium species were excluded by us-
ing a conventional nested PCR and real-time PCR (8,9). In 
addition, PCR analysis was performed on a blood sample 
by using diagnostic primers for Plasmodium small subunit 
(SSU)  rRNA  as  described  (3),  including  genus-specific 
and species-specific primers. In contrast to the method de-
scribed by Singh et al. (3), nested PCR was not necessary 
because of high parasitemia and availability of fresh ma-
terial. Instead, PCRs were performed directly on 2 µL of 
blood in 25-µL volumes by using the Phusion Blood PCR 
kit  (Finnzymes,  Espoo,  Finland).  Genus-specific  primer 
sets and P. knowlesi–specific primers generated PCR prod-
ucts, providing evidence that the patient had P. knowlesi 
malaria.
To confirm the PCR result, we sequenced the cloned 
amplification product generated with primers rPLU1 and 
rPLU5. Sequences were compared with known Plasmo-
dium A-type SSU rRNA sequences by using the neighbor-
joining method (Figure 2). The sequence of the clinical iso-
late PkHHR-BPRC1 (GenBank accession no. FJ804768) 
clustered strongly with P. knowlesi A-type SSU RNA se-
quences, confirming that the patient was infected with the 
P. knowlesi parasite.
Conclusions
Imported  malaria  is  relatively  rare  in  industrialized 
countries. Obtaining a correct diagnosis of malaria may 
be troublesome in centers where laboratory staff are less 
skilled  in  the  proper  identification  and  quantification  of 
causative Plasmodium species, as may occur in countries 
in which malaria is not endemic. These centers often use 
commercially available rapid diagnostic tests to diagnose 
malaria. In contrast to our case, Bronner et al. reported that 
the BinaxNOW Malaria Test did not detect a P. knowlesi 
infection in a traveler from Sweden who had a P. knowlesi 
infection  acquired  in  Malaysian  Borneo  (2).  Low  para-
sitemia (0.1%) in this patient may have caused the lack of 
reactivity with the pan-malarial antigen aldolase (2).
We  evaluated  the  BinaxNOW  Malaria  and  the   
OptiMAL Rapid Malaria (Diamed, Cressier, Switzerland) 
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Figure	1.	Morphology	of	Plasmodium knowlesi	in	a	Giemsa-stained	thin	blood	smear.	Infected	erythrocytes	were	not	enlarged,	lacked	
Schuffner	stippling,	and	contained	much	pigment.	Shown	are	examples	of	trophozoites	(A–F),	a	schizont	(G),	and	a	gametocyte	(H).	Scale	
bars	=	5	µm. 
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Figure	2.	Phylogenetic	tree	constructed	according	to	the	neighbor-
joining	method	based	on	A-type	small	subunit	RNA	sequences	of	
several  Plasmodium	 species	 (GenBank	 accession	 numbers	 are	
indicated).	 The	 sequence	 of	 the	 clinical	 isolate	 PkHHR-BPRC1	
(in boldface)	(GenBank	accession	no.	FJ804768)	clusters	with	all	
other P. knowlesi	strains	(indicated	by	Pk	isolate	numbers).	Pfrag,	P. 
fragile;	Pinui,	P. inui;	Pcyn,	P. cynomolgi;	Pfalc,	P. falciparum;	Pmal,	
P. malariae. Scale	bar	indicates	nucleotide	substitutions	per	site.tests for detection of P. knowlesi in human blood by anal-
ysis of consecutive blood samples taken after admission. 
These samples were stored at –20°C for 2 weeks until 
tests were performed (Table). The blood sample taken on 
admission (2% infected erythrocytes) did not react with P. 
falciparum–specific antibody against histidine-rich pro-
tein 2 but reacted with the pan-malarial antigen aldolase 
in the BinaxNOW Malaria Test. This sample also showed 
a positive result in the P. falciparum–specific LDH and 
pan-malarial LDH in the OptiMAL Rapid Malaria Test, 
confirming the cross-reactivity of P. knowlesi LDH with 
monoclonal antibody 17E4 against P. falciparum LDH, 
as shown by McCutchan et al. (10). This antibody is also 
used in the OptiMAL Rapid Malaria Test (Diamed, pers. 
comm.). Therefore, a positive test result for the P. falci-
parum LDH in the OptiMAL Rapid Malaria Test is not 
specific for P. falciparum because it can also be caused 
by a P. knowlesi infection. The positive result for LDH 
and aldolase in either test became negative after treatment 
(Table), which indicates rapid clearance of parasites after 
treatment. Results of our comparative study suggest that the 
OptiMAL Rapid Malaria Test may be able to detect lower 
levels  of  P.  knowlesi  parasitemia  than  the  BinaxNOW   
Malaria Test.
Our results indicate that commercially available rapid 
diagnostic antigen tests for human Plasmodium species can 
detect P. knowlesi infections in humans, although infec-
tions with a low parasitemia will not be detected. A nega-
tive test result does not exclude a P. knowlesi infection, as 
it does not exclude infections by other human Plasmodium 
species (11).
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Table.	Evaluation	of	2	commercially	available	rapid	diagnostic	antigen	tests used for detection of Plasmodium knowlesi*
BinaxNOW†	 Diamed OptiMAL‡	 Time after 
admission, h 
P. knowlesi parasitemia,
trophozoites/PL HRP-2 Aldolase P. falciparum–LDH	 Pan-malarial	LDH	
0 84,000 –§ +§ + +
16 1,587 –§ –§ + +
24 138 – – – –
40 ND – – – –
*HRP-2,	histidine-rich	protein	2;	LDH,	lactate	dehydrogenase;	ND,	not	detectable. All tests were preformed on blood samples collected in EDTA and 
frozen	at	–20°C	for	2	weeks.	
†Binax,	Inc.,	Scarborough,	ME,	USA	
‡Diamed,	Cressier,	Switzerland.	
§Tests were also performed on freshly collected	blood	samples;	results	were	identical.		